Can "steroid switching" improve steroid-induced psychosis in a patient with advanced cancer?

Journal of Palliative Medicine

Volumn 12, Issue 5, 2009, Pages 487-490

  Okishiro, Nao ^a,d   Tanimukai, Hitoshi ^b,c   Tsuneto, Satoru ^c   Ito, Noriyuki ^a  

^a Gratia Hospital   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Gratia Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; FENTANYL; MIDAZOLAM; PREDNISOLONE; SECOBARBITAL;

ADVANCED CANCER; AGED; AMNESIA; ARTICLE; BEHAVIOR DISORDER; BRONCHUS SECRETION; CANCER PALLIATIVE THERAPY; CASE REPORT; CORTICOSTEROID THERAPY; DAILY LIFE ACTIVITY; DELIRIUM; DISORIENTATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EATING; EVENING DOSAGE; FACIAL EXPRESSION; FUNCTIONAL DISEASE; GAZE; HEALTH CARE PERSONNEL; HUMAN; INSOMNIA; INTUBATION; LUNG EMPHYSEMA; MALE; MALIGNANT MESOTHELIOMA; MORNING DOSAGE; PAIN; PLEURA MESOTHELIOMA; PSYCHOSIS; RESTLESSNESS; SIDE EFFECT; TIME PERCEPTION; TRACHEOTOMY; VERBAL BEHAVIOR;

ADMINISTRATION, ORAL; AGED; BETAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEOPLASMS; PALLIATIVE CARE; PREDNISOLONE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 66749128494     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.9628     Document Type: Article

References (27)

1. Ross DD, Alexander CS: Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, ca-chexia, nausea and vomiting. Am Fam Physician 2001;64: 807-814.
2. Watanabe S, Bruera E: Corticosteroids as adjuvant analgesics. J Pain Symptom Manage 1994;9:442-445.
3. Lewis DA, Smith RE: Steroid-induced psychiatric syndromes: A report of 14 cases, and a review of the literature. J Affect Disord 1983;5:319-332.
4. Patten SB, Neutel CI: Corticosteroid-induced adverse psychiatric effects: Incidence, diagnosis and management. Drug Saf 2000;22:111-122.
5. Brown ES, Khan DA, Nejtek VA: The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 1999; 83(6 Pt 1):495-503.
6. Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M: An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord 2004;83:277-281.
7. Buchman AL: Side effects of corticosteroid therapy. J Clin Gastroenterol 2001;33:289-294.
8. Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S: Corticosteroid-induced psychotic and mood disorders: Diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001;42:461-466.
9. Warrington TP, Bostwick JM: Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006;81:1361-1367.
10. Wolkowitz OM, Epel ES, Reus VI: Stress hormone-related psychopathology: Pathophysiological and treatment implications. World J Biol Psychiatry 2001;2:115-143.
11. Brown ES, Chandler PA: Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 2001;3:17-21.
12. Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B: Effects of chronic prednisone therapy on mood and memory. J Affect Disord 2007;99:279-283.
13. Ferris RL, Eisele DW: Steroid psychosis after head and neck surgery: Case report and review of the literature. Otolaryngol Head Neck Surg 2003;129:591-592.
14. Naber D, Sand P, Heigl B: Psychopathological and neu-ropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996;21:25-31.
15. Sirois F: Steroid psychosis: a review. Gen Hosp Psychiatry 2003;25:27-33.
16. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D: Cognitive effects of corticosteroids. Am J Psychiatry 1990;147:1297-1303.
17. Morrison C: Identification and management of delirium in the critically ill patient with cancer. AACN Clin Issues 2003;14:92-lll.
18. Ross DD, Alexander CS: Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea. Am Fam Physician 2001;64:1019-1026.
19. Lagman RL, Davis MP, LeGrand SB, Walsh D: Common symptoms in advanced cancer. Surg Clin North Am 2005;85:237-255.
20. Carter GL, Dawson AH, Lopert R: Drug-induced delirium. Incidence, management and prevention. Drug Saf 1996;15:291-301.
21. Gray SL, Lai KV, Larson EB: Drug-induced cognition disorders in the elderly: Incidence, prevention and management. Drug Saf 1999;21:101-122.
22. Moore AR, O'Keeffe ST: Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
23. Matsuo N, Morita T. Efficacy, safety, and cost effectiveness of intravenous midazoram and flunitrazepam for primary insomnia in terminally ill patients with cancer: A retrospective multicenter audit study. J Palliat Med 2007;10:1054-1062.
24. Glynne-Jones R, Vernon CC, Bell G: Is steroid psychosis preventable by divided doses? Lancet 1986;2:1404.
25. Schimmer BP, Parker KL. Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Brunton LL, Lazo JS, Parker KL (eds): Goodman and Gil-man's The Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill, 2006, pp. 1587-1612.
26. Greeves JA: Rapid-onset steroid psychosis with very low dosage of prednisolone. Lancet 1984;1:1119-1120.
27. Mercadante S, Bruera E. Opioid switching: A systematic and critical review. Cancer Treat Rev 2006;32:304-315.